secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0000950170-22-020636
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus Pharmaceuticals amends loan agreement, defers principal payments, adjusts conversion prices on $2M of debt
--------------------------------------------------------------------------------

- Principal repayments deferred from Sept 2022 to Sept 2023; if Co. raises ≥$30M, extended to March 2024.
- Conversion price on $875K debt lowered to $0.15/share, $1.125M to $0.2625/share (from $9.40).
- Company paid $100K at amendment and will pay $400K at loan maturity.
- Lenders refunded Sept & Oct 2022 principal payments already made.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017022020636/0000950170-22-020636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017022020636/crbp-20221025.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-020636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer